Ziprasidone, Serum or Plasma
2007955
 
Ordering Recommendation
Therapeutic monitoring of ziprasidone (eg, Zeldox, Geodon).
Mnemonic
ZIPRASIDO
Methodology
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun, Wed
Reported
1-5 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Pre-dose (trough) draw - At steady state concentration.  
Collect
Lavender (EDTA), pink (K2EDTA) or plain red.  
Specimen Preparation
Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to an ARUP Standard Transport Tube. (Min: 0.5 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Whole blood. Gel separator tubes, light blue (citrate), or yellow (SPS or ACD solution).  
Remarks
 
Stability
Ambient: 2 weeks Refrigerated: 2 weeks; Frozen: 2 weeks  
Reference Interval
Therapeutic range Not well established
Proposed Dose-​Related Range 50-​200 ng/mL
Toxic range Not well established
Interpretive Data
Adverse effects to ziprasidone therapy may include headache, postural hypotension, tachycardia and dyskinesia.

See Compliance Statement B: www.aruplab.com/CS
Note
CPT Code(s)
80299
Components
Component Test Code*Component Chart Name
2007956Ziprasidone Serum/Plasma
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • geodon blood concentration
  • zeldex blood concentration
  • Zeldox, Geodon
  • ziprasidone blood level